These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K. Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474 [Abstract] [Full Text] [Related]
18. Treatment of diffuse alveolar hemorrhage in systemic lupus erythematosus patient with local pulmonary administration of factor VIIa (rFVIIa): a case report. Alabed IB. Medicine (Baltimore); 2014 Sep; 93(14):e72. PubMed ID: 25255019 [Abstract] [Full Text] [Related]
20. Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies. Chu T, Tang Y, Wang H, Qi J, Zhao Y, Pan T, Tang X, Qiu H, Fu C, Ruan C, Wu DP, Han Y. Thromb Res; 2017 Dec; 160():14-18. PubMed ID: 29080548 [Abstract] [Full Text] [Related] Page: [Next] [New Search]